Document Detail


Endogenous sex hormones and cardiovascular disease in men.
MedLine Citation:
PMID:  14602729     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Unlike women, men do not experience an abrupt reduction in endogenous sex hormone production. It has, however, become clear that an age-associated decrease in the levels of (bioactive) sex hormones does occur. Whether endogenous sex hormones have an impact on cardiovascular disease has for many years remained largely unknown, but during the last decade more attention has been drawn to the importance of testosterone, estrogens, and adrenal androgens in etiology, prevention, and treatment of male cardiovascular disease. The purpose of this article is to summarize the evidence currently available on the association between endogenous sex hormones and cardiovascular disease in males. Published studies dealing with the relationship between circulating levels of sex hormones and cardiovascular disease in males were reviewed. The studies reviewed in this article suggest that circulating endogenous sex hormones and estrogens have a neutral or beneficial effect on cardiovascular disease in men.
Authors:
Majon Muller; Yvonne T van der Schouw; Jos H H Thijssen; Diederick E Grobbee
Related Documents :
9457449 - Disease burden of cardiovascular disease in the elderly.
21841729 - Vasculitic neuropathy.
16198279 - Cardiovascular disease in children with chronic kidney disease.
19131029 - Cardiovascular physiology and diseases of amphibians.
15278009 - Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease.
19065999 - Detection of metabolic syndrome features among childhood cancer survivors: a target to ...
22265399 - Chromothripsis and human disease: piecing together the shattering process.
20435169 - The telomere/telomerase system in autoimmune and systemic immune-mediated diseases.
16319329 - Effects of exacerbations and seasonality on exhaled nitric oxide in copd.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  88     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-06     Completed Date:  2003-12-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5076-86     Citation Subset:  AIM; IM    
Affiliation:
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiovascular Diseases / epidemiology*,  metabolism*
Dehydroepiandrosterone / metabolism*
Humans
Male
Risk Factors
Testosterone / metabolism*
Chemical
Reg. No./Substance:
53-43-0/Dehydroepiandrosterone; 58-22-0/Testosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical review 165: Markers of bone remodeling in metastatic bone disease.
Next Document:  Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell ...